No matter the industry, collaborations between multiple parties throughout a project pipeline can prove challenging.
In pharmaceutical development, collaborating with multiple Contract Development and Manufacturing Organizations (CDMOs) and Contract Research Organizations (CROs) poses potential hurdles - from poor communication to delays, errors, and inconsistent feedback during the progression from preclinical to formulation optimization and clinical trials.
Discover how a dedicated program management solution ensures seamless operations and streamlined communication through a single point of contact.
Download Now
Asset 8: Streamline your drug development pathway from preclinic to FIH/POC
PDF, Size 0 kb
